This inventor holds 1 USPTO granted patent. Top assignee: Pliva Farmaceutiska, Kemijska, Prehrambena I Kozmeticka Industrija,. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Nedjeliko Kujund Zi C: Innovator in Macrolide Antibiotics
Introduction
Nedjeliko Kujund Zi C is a notable inventor based in Zagreb, Croatia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel antibiotics. His work focuses on enhancing the efficacy of treatments for bacterial infections.
Latest Patents
Nedjeliko holds a patent for the invention titled "9A-N-(N'-carbamoyl) and 9A-N-(N'-thiocarbamoyl) derivatives." This invention relates to 9a-N-(N'-carbamoyl) and 9a-N-(N'-thiocarbamoyl) derivatives of 9-deoxo-9a-aza-9a-homoerythromycin A. These compounds are classified as novel semisynthetic macrolide antibiotics of the azalide series. The formula includes variations where R represents a C1-C3 alkyl, aryl, or aralkyl group, and X can be either O or S. The patent also covers pharmaceutically acceptable addition salts with inorganic or organic acids, as well as the intermediates and processes for their preparation. Furthermore, it details the preparation of pharmaceutical compositions and their use in treating bacterial infections.
Career Highlights
Nedjeliko is associated with Pliva Farmaceutiska, Kemijska, Prehrambena I Kozmeticka Industrija, a prominent pharmaceutical company. His work there has been instrumental in advancing antibiotic research and development. He has a strong focus on creating effective treatments that address pressing health concerns.
Collaborations
Nedjeliko has collaborated with several professionals in his field, including Gabrijela Kobrehel and Zeljko Kelneri C. These collaborations have contributed to the successful development of his patented innovations.
Conclusion
Nedjeliko Kujund Zi C is a distinguished inventor whose work in macrolide antibiotics has the potential to significantly impact the treatment of bacterial infections. His innovative approach and dedication to pharmaceutical research continue to pave the way for advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile